Error: Could not add to watchlist. X

Nektar Therapeutics

+ Watchlist
ITH:GR
Frankfurt
11.10
EUR
0.21
1.89%
As of 09:35:44 ET on 06/30/2015.
Open
10.93
Day Range
10.93 - 11.24
Volume
300
Previous Close
10.89
52Wk Range
7.76 - 13.64
1 Yr Return
18.17%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (b EUR)
1.460
Shares Outstanding (m)
131.526
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.
ADDRESS
455 Mission Bay Blvd South
San Francisco, CA 94158
United States
PHONE
1-415-482-5300
  • Howard W Robin
    President/CEO
  • John L Nicholson
    Senior VP/CFO
  • Stephen K Doberstein
    Senior VP/Chief Scientific Ofcr
  • Gil M Labrucherie
    Senior VP/Secy/Gen Counsel
  • Jillian B Thomsen
    Senior VP:Finance
Show More